Artículos,
noticias y otros contenidos relacionados con la Seguridad del Paciente
en general y especialmente en Atención Primaria, publicados en nuestra
cuenta de Twitter @sanoysalvoblog*.
La #FDA ha publicado una guía sobre #app médicas y supervisará las que funcionan como dispositivos médicos http://t.co/dNhsJu3FRC #SegPac
— Sano y salvo (@sanoysalvoblog) September 29, 2013
Las #app de dermatología para médicos y usuarios pueden comprometer la seguridad de los pacientes http://t.co/U6UoIzqSZc #SegPac
— Sano y salvo (@sanoysalvoblog) September 29, 2013
Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey http://t.co/QIDzBbuQi1 #PtSafety
— Sano y salvo (@sanoysalvoblog) September 29, 2013
Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006 http://t.co/LqhbahcmpA #PtSafety
— Sano y salvo (@sanoysalvoblog) September 30, 2013
“@AEMPSGOB: Jornada informativa sobre novedades en la farmacovigilancia de los medicamentos http://t.co/mhT9QWvQgr” #SegPac
— Sano y salvo (@sanoysalvoblog) September 30, 2013
Dose-Related Paresthesias With Venlafaxine http://t.co/F7aAu5qVuH vía @RaulCalvoRico #PtSafety
— Sano y salvo (@sanoysalvoblog) September 30, 2013
Sistema informático de notificación de incidentes de seguridad del paciente en atención primaria: impl... http://t.co/WICdzcrn4i #SegPac
— Sano y salvo (@sanoysalvoblog) October 1, 2013
(BMJ) European regulator is urged to release data on drugs approved in past 10 years http://t.co/JEwn4hYu9h #transparency #PtSafety
— Sano y salvo (@sanoysalvoblog) October 1, 2013
(AFP Community blog) Health checks increase diagnoses, but do they improve health? http://t.co/XSFOoV3o2L #PtSafety
— Sano y salvo (@sanoysalvoblog) October 1, 2013
(Australian Prescriber) Empleo de medicamentos antiasmáticos en el embarazo y la lactancia http://t.co/VlH985p84E más beneficios que riesgos
— Sano y salvo (@sanoysalvoblog) October 1, 2013
(Farmacovigilancia Australia) Medicamentos que pueden causar daño hepático http://t.co/rx3ejzdgbz #SegPac
— Sano y salvo (@sanoysalvoblog) October 1, 2013
(Farmacovigilancia Australia) Atomoxetina y suicidio en niños y adolescentes http://t.co/rx3ejzdgbz #SegPac
— Sano y salvo (@sanoysalvoblog) October 1, 2013
Anyone interested in the science of Overdiagnosis, the BMJ's Too Much Medicine series is worth a look - see this page http://t.co/sCFc8RXfJC
— Ray Moynihan (@raymoynihan) September 30, 2013
¿Qué significa el triángulo negro? Este video de @EMA_News explica http://t.co/Aq3oANc9GK #medicines #pharmacovigilance #blacktriangle
— EAHP (@EAHPtweet) October 1, 2013
Quality and safety of care provided by the NHS: More dialogue, more learning, more action. BMJ Qual Saf http://t.co/GN8HBKfGDh #PtSafety
— Sano y salvo (@sanoysalvoblog) October 1, 2013
A menos q estés a favor del ocultamiento de evidencia, deberías firmar estas 2 peticiones: - http://t.co/FauBygXNRe - http://t.co/BxgxYAafHl
— Médicos Sin Marca (@MedicosSinMarca) September 30, 2013
Uso racional y seguro de los corticoides tópicos (Australian Prescriber) http://t.co/2VTOhbRlEf vía @Sefap_FAP #SegPac
— Sano y salvo (@sanoysalvoblog) October 1, 2013
@DavidJuurlink Yes, it's 1 case: in most cases Metformin is an effective and safe treatment in type 2 diabetes http://t.co/D1fe9rmKhi
— Sano y salvo (@sanoysalvoblog) October 1, 2013
@sanoysalvoblog Article makes a good point about underuse of metformin in renal disease. Irrational to avoid rather than adjust dose.
— David Juurlink (@DavidJuurlink) October 1, 2013
Can Psychotic Side Effects be Triggered by the Drugs My Child is Taking for ADHD? http://t.co/jM1VF0mbVy RxView blog post from @KeithAEI
— AdverseEvents (@AdverseEvent) October 2, 2013
(e-butlletí groc) Seguimiento a largo plazo del estudio WHI con THS http://t.co/0yA1hWlCkA #SegPac
— Sano y salvo (@sanoysalvoblog) October 2, 2013
(NPS) Can taking Nexium (esomeprazole) contribute to osteoporosis? http://t.co/jF01DHMyzY #PtSafety
— Sano y salvo (@sanoysalvoblog) October 2, 2013
(NPS) Oral antibiotics: an option in acne but consider the risks http://t.co/D0r38PghSG #PtSafety
— Sano y salvo (@sanoysalvoblog) October 2, 2013
Risk–Benefit Profile of Long-Term Dual- Versus Single-Antiplatelet Therapy Among Patients With Ischemic Stroke http://t.co/RK7ymkAF28
— Sano y salvo (@sanoysalvoblog) October 2, 2013
(Circulation) Management and Outcomes of Major Bleeding during Treatment with Dabigatran or Warfarin http://t.co/8nqh3I06fm #PtSafety
— Sano y salvo (@sanoysalvoblog) October 2, 2013
Efectos adversos del ranelato de estroncio, antidepresivos ISRS, terbinafina y Goji + ACO. Prescrire http://t.co/D0eEIBR4t9 #PtSafety
— Sano y salvo (@sanoysalvoblog) October 2, 2013
Medicamentos con triángulo negro▼sujetos a vigilancia más estricta de su seguridad. Actualización de la @AEMPSGOB #SegPac #Farmacovigilancia
— Sano y salvo (@sanoysalvoblog) October 2, 2013
Opiáceo trimebutina en dolor abdominal: riesgo d abuso y adicción; si sobredosis, d daño neurológico/cardíaco http://t.co/ivAAgtlyer #SegPac
— Sano y salvo (@sanoysalvoblog) October 2, 2013
Canadian doctors join campaign against unnecessary tests and treatments | BMJ http://t.co/RYu73rvMdy #PtSafety
— Sano y salvo (@sanoysalvoblog) October 2, 2013
What went wrong with the quality and safety agenda? An essay by Michael Buist and Sarah Middleton | BMJ http://t.co/K3tcDKppJ3 #PtSafety
— Sano y salvo (@sanoysalvoblog) October 2, 2013
MT @ernestob Riesgos x interacción entre medicamentos coadministrados por vía tópica y sistémica http://t.co/63BA1LEnsB #SegPac
— Sano y salvo (@sanoysalvoblog) October 3, 2013
“@juanjojurado Similitud de envases, riesgo de confusión entre vacuna antitetánica y vacuna de gripe pic.twitter.com/zQnM751KiS” #SegPac
— Sano y salvo (@sanoysalvoblog) October 3, 2013
“@JAMAInternalMed: Choosing Wisely, and Soon http://t.co/xye0YkgGe8” #PtSafety
— Sano y salvo (@sanoysalvoblog) October 4, 2013
Find out what the #blacktriangle means and how additional monitoring works: http://t.co/ZzDNIqm0Nk
— EU Medicines Agency (@EMA_News) October 4, 2013
We've started publishing recommendations based on safety signals: http://t.co/4TcedOgAR9 #pharmacovigilance
— EU Medicines Agency (@EMA_News) October 4, 2013
MT @FarmaciaOesteAP Boletín RAM Madrid: Hipo por medicamentos https://t.co/9pmASQNp4o #SegPac
— Sano y salvo (@sanoysalvoblog) October 4, 2013
MT @FarmaciaOesteAP Boletín RAM Madrid: Alteraciones hepáticas agudas por medicamentos: diagnóstico y pronóstico https://t.co/5CZOgBnMga
— Sano y salvo (@sanoysalvoblog) October 4, 2013
Interesante entrada sobre #Segpac y notificación de reacciones adversas a medicamentos http://t.co/4lvIBolSxD por @drlopezheras
— Pastora Pérez (@pasperper) October 4, 2013
El nuevo plan de salud vasco dará prioridad a la seguridad de los pacientes http://t.co/w9Lwf9TodM vía @elmundoes
— Sano y salvo (@sanoysalvoblog) October 4, 2013
(JAMA Ophthalmol) Association of Statin Use With Cataracts: A Propensity Score-Matched Analysis http://t.co/kofAI1LAtj #PtSafety
— Sano y salvo (@sanoysalvoblog) October 4, 2013
Idiopathic Acute Liver Injury in Paediatric Outpatients: Incidence and Signal Detection in Two European Countries http://t.co/uc0iYquGlC
— Sano y salvo (@sanoysalvoblog) October 4, 2013
Prescribing advice for GPs: Saxagliptin fails to reduce cardiovascular events http://t.co/6V6vvr2T2n #PtSafety
— Sano y salvo (@sanoysalvoblog) October 4, 2013
Effects of internet-based training on ATB prescribing rates for acute respiratory-tract infections:controlled trial http://t.co/hyAyxptoNF …
— Sano y salvo (@sanoysalvoblog) October 4, 2013
(BMJ) When good care means less pay http://t.co/eYcMAN1IY0 #PtSafety
— Sano y salvo (@sanoysalvoblog) October 4, 2013
Promotional material UK: European Antibiotic Awareness Day: Resources for primary and secondary care https://t.co/laFoEgvaHc #PtSafety
— Sano y salvo (@sanoysalvoblog) October 4, 2013
Poster UK Government: no amount of antibiotics will get rid of your cold https://t.co/laFoEgvaHc #PtSafety #AntibioticAwarenessDay2013
— Sano y salvo (@sanoysalvoblog) October 4, 2013
Leaflet UK Government: get well soon without antibiotics https://t.co/6wkIWmmYUc #PtSafety #AntibioticAwarenessDay2013
— Sano y salvo (@sanoysalvoblog) October 4, 2013
Selective serotonin re-uptake inhibitors: a review of the side effects in adolescents http://t.co/MOePoLyLOM vía @DavidJuurlink #PtSafety
— Sano y salvo (@sanoysalvoblog) October 5, 2013
Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium Guidance http://t.co/Hu1OdsoEGW #PtSafety
— Sano y salvo (@sanoysalvoblog) October 5, 2013
“@AEMPSGOB: Video ¿Qué significa el triángulo negro? http://t.co/7zC2kjFOfF” #SegPac
— Sano y salvo (@sanoysalvoblog) October 5, 2013
Información sobre Medicamentos sometidos a seguimiento adicional de su seguridad http://t.co/EorzjJXWWN
— AEMPS (@AEMPSGOB) October 2, 2013
Applying ethnography to the study of context in healthcare quality and safety @BMJ_Qual_Saf http://t.co/JPO00JxDmy #PtSafety
— Sano y salvo (@sanoysalvoblog) October 5, 2013
Have we gone too far in translating ideas from aviation to patient safety? Yes | BMJ http://t.co/OkhMuDcK8o #PtSafety
— Sano y salvo (@sanoysalvoblog) October 6, 2013
Have we gone too far in translating ideas from aviation to patient safety? No | BMJ http://t.co/qkAfqikfuQ #PtSafety
— Sano y salvo (@sanoysalvoblog) October 6, 2013
*El equipo que mantiene @sanoysalvoblog está compuesto por Cecilia Calvo Pita @cecilicp y Jesús Palacio Lapuente @je_pala.
Realiza la publicación de estas selecciones Txema Coll Benejam @txemacoll.
0 comentarios:
Publicar un comentario